Researchers report promising plant-made antimicrobial peptide (PMAMP) for topical, low-cost disruption of oral biofilm

The protein drug rapidly killed Streptococcus mutans and impaired biofilm formation with a single application.
Nov. 14, 2016

In the October issue of Biomaterials, researchers at the University of Pennsylvania School of Dental Medicine published findings on a low-cost protein drug that holds promise for caries control. The topical drug utilizes two plant-made antimicrobial peptides (PMAMPs), retrocyclin and protegrin, along with a novel delivery system to control biofilm and quickly neutralize Streptococcus mutans.

Read more about the researchers' findings here.

About the Author

Apex360 Editors

Apex360, a member of the DentistryIQ Network, features news and information on the dental industry.

  • Visit the Apex360 home page (DentistryIQ Industry Topic Center) here.
  • Subscribe to the Apex360 newsletter here.

Updated April 22, 2016

Sign up for DentistryIQ Newsletters
Get the latest news and updates.